دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(24)00085-9
Volume 192, March 2024, 110164
MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters
Mette van Overeem Felter a,*, Pia Krause M?ller b,h, Mirjana Josipovic c,g, Susanne N?rring Bekke a, Uffe Bernchou b,f, Eva Serup-Hansen a, Kasper Madsen a, Parag J. Parikh d, Joshua Kim d, Poul Geertsen a, Claus P. Behrens a,e, Ivan R. Vogelius c,g, Mette P?hl c, Tine Schytte b,f, Gitte Fredberg Persson
doi : 10.1016/j.radonc.2024.110090
Volume 192, March 2024, 110090
A taskforce for national improvement of innovation implementation in radiotherapy
Maria Jacobs a,*, Hanneke Martinussen b, Rachelle Swart b, Anne Gubbels b, Maarten Dirkx c, Hans de Boer d, Gabrielle Speijer e, Karin Mondriaan f, Katrien de Jaeger g, Johan Cuijpers h, Mirjam Mast i, Floortje de Vreugt j, Liesbeth Boersma
doi : 10.1016/j.radonc.2024.110105
Volume 192, March 2024, 110105
Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study
Qiaojuan Guo a,b,1, Tianzhu Lu c,d,1, Wanfang Huang a,1, Hanchuan Xu a, Quxia Zhang a, Yun Xiao c,d, Jing Zhong e, Honghui Xie c,d, Jihong Chen a, Jingfeng Zong a, Xiaochang Gong c,d, Jianji Pan a,b, Jingao Li c,d,*, Shaojun Lin
doi : 10.1016/j.radonc.2024.110086
Volume 192, March 2024, 110086
Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort
Micha¨el H. Frank a,b,c,*, Boukje A.C. van Dijk b,d, Rosanne C. Schoonbeek e, Jaap Zindler f, Lot A. Devriese g, Robert J.J. van Es a, Matthias A.W. Merkx b,h, Remco de Bree
doi : 10.1016/j.radonc.2024.110107
Volume 192, March 2024, 110107
Obstructive sleep apnea syndrome: A frequent and difficult-to-detect complication of radiotherapy for oropharyngeal cancers
Florent Carsuzaa a,*, El´eonore Chary b, Juliette Thariat c, Xavier Dufour a, Valentin Favier
doi : 10.1016/j.radonc.2024.110109
Volume 192, March 2024, 110109
Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease
Shin-Hyung Park a,b,1,*, Jae-Kwang Lim c,1, Min Kyu Kang a, Jongmoo Park a, Chae Moon Hong d, Chang Ho Kim e, Seung Ick Cha e, Jaehee Lee e, Seoung-Jun Lee f, Jae-Chul Kim
doi : 10.1016/j.radonc.2023.110053
Volume 192, March 2024, 110053
Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis
Gerard M. Walls a,b,*, Conor McCann c, John O’Connor d, Anna O’Sullivan e, David I. Johnston b, Jonathan McAleese a, Conor K. McGarry a,b, Aidan J. Cole a, Suneil Jain a,b, Karl T. Butterworth b, Gerard G. Hanna
doi : 10.1016/j.radonc.2024.110085
Volume 192, March 2024, 110085
Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions – A systematic review and meta-analysis
Aneesh Dhar a, Jose de Jesus Cendejas-Gomez b, Lucas Castro Mendez a, Gabriel Boldt b, Eric McArthur b, Constantinos Zamboglou c,d, Glenn Bauman
doi : 10.1016/j.radonc.2023.110070
Volume 192, March 2024, 110070
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Philip J. Saylor a,1, Sergey V. Kozin b,1, Aya Matsui b, Saveli I. Goldberg b, Shuichi Aoki b, Kohei Shigeta b, Emilie Mamessier b, Matthew R. Smith a, M. Dror Michaelson a, Richard J. Lee a, Dan G. Duda
doi : 10.1016/j.radonc.2024.110091
Volume 192, March 2024, 110091
The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A national population-based evaluation
Lu Han a, Richard Sullivan b, Alison Tree c, Daniel Lewis a, Pat Price d, Vijay Sangar e,f, Jan van der Meulen a, Ajay Aggarwal
doi : 10.1016/j.radonc.2024.110092
Volume 192, March 2024, 110092
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
Giuseppe Sanguineti a, Maddalena Pavarini b, Fernando Munoz c, Alessandro Magli d, Domenico Cante e, Elisabetta Garibaldi c, Andrea Gebbia b, Barbara Noris Chiorda f, Giuseppe Girelli g, Elisa Villa h, Adriana Faiella a, Justyna Magdalena Waskiewicz i, Barbara Avuzzi f, Alice Pastorino j, Eugenia Moretti k, Luciana Rago l, Teodora Statuto m, Marco Gatti n, Tiziana Rancati o, Riccardo Valdagni f, Vittorio Luigi Vavassori h, Nadia Gisella Di Muzio p,q, Claudio Fiorino b, Cesare Cozzarini
doi : 10.1016/j.radonc.2024.110088
Volume 192, March 2024, 110088
Evaluating AI-generated CBCT-based synthetic CT images for target delineation in palliative treatments of pelvic bone metastasis at conventional C-arm linacs
Nienke Hoffmans-Holtzer a,*,1,3, Alba Magallon-Baro a,1,2,3, Ilse de Pree a, Cleo Slagter a, Jiaofeng Xu b, Daniel Thill b, Manouk Olofsen-van Acht a, Mischa Hoogeman a, Steven Petit
doi : 10.1016/j.radonc.2024.110110
Volume 192, March 2024, 110110
DIVE-ART: A tool to guide clinicians towards dosimetrically informed volume editions of automatically segmented volumes in adaptive radiation therapy
Benjamin Roberfroid a,*, John A. Lee a, Xavier Geets a,b, Edmond Sterpin a,c,d, Ana M. Barrag´an- Montero
doi : 10.1016/j.radonc.2024.110108
Volume 192, March 2024, 110108
Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients – A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia
Grace C. Blitzer a, Cristina Paz a, Annemarie Glassey a, Olga R. Ganz b, Jayeeta Giri b, Andrea Pennati b,e, Ross O. Meyers a,b, Amber M. Bates a, Kwangok P Nickel a, Marissa Weiss a, Zachary S. Morris a, Ryan J. Mattison b,e, Kimberly A. McDowell b, Emma Croxford c, Richard J. Chappell c,e, Tiffany A. Glazer d, Nicole M. Rogus-Pulia b,e,f, Jacques Galipeau b,e, Randall J. Kimple
doi : 10.1016/j.radonc.2024.110093
Volume 192, March 2024, 110093
Characterisation of quantitative imaging biomarkers for inflammatory and fibrotic radiation-induced lung injuries using preclinical radiomics
Kathryn H. Brown a,*, Mihaela Ghita-Pettigrew a, Brianna N. Kerr a, Letitia Mohamed-Smith a, Gerard M. Walls a,b, Conor K. McGarry b, Karl T. Butterworth
doi : 10.1016/j.radonc.2024.110106
Volume 192, March 2024, 110106
Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trials
Suresh Senan a,*, Famke L. Schneiders a, Drew Moghanaki
doi : 10.1016/j.radonc.2024.110094
Volume 192, March 2024, 110094
Evaluation of post-lung SABR imaging: A proposed pathway
De Bruycker Aur´elie
doi : 10.1016/j.radonc.2024.110083
Volume 192, March 2024, 110083
Response to evaluation of post-lung SABR imaging: A proposed pathway
Stephanie Gulstene, David A. Palma
doi : 10.1016/j.radonc.2024.110080
Volume 192, March 2024, 110080
Comment on: Improved local control following dose-escalated Stereotactic Ablative Radiation Therapy (SABR) for metastatic sarcomas: An international multi-institutional experience
Yupeng Dia, Jiazhao Songa, Lingling Meng
doi : 10.1016/j.radonc.2023.110062
Volume 192, March 2024, 110062
In Reply To: Comment on: Improved local control following dose-escalated stereotactic ablative radiation therapy (SABR) for metastatic sarcomas: An international multi-institutional experience
Raj Singh
doi : 10.1016/j.radonc.2023.110058
Volume 192, March 2024, 110058
